Suzanne Jacques-O'Hagan

Suzanne Jacques-O'Hagan's work experience includes serving as the Director of Biochemistry at Nimbus Therapeutics since March 2020. Prior to that, they worked at Epizyme, where they held various roles including Associate Director of Lead Discovery from August 2018 to March 2020, Principal Scientist of Lead Discovery from December 2012 to August 2018, and Contract Scientist from November 2011 to December 2012. Before joining Epizyme, they were the Enzymology Lead at New England PharmAssociates from April 2010 to June 2011. Suzanne began their career as a Principal Scientist at Pfizer Inc from December 2004 to February 2010. Suzanne also served as a Post-Doctoral Fellow at Tufts University from October 1998 to November 2004.

Suzanne Jacques-O'Hagan has a Bachelor of Science degree in Biochemistry (Honors) from McGill University. Suzanne also holds a Master of Applied Science degree in Chemical Engineering from the University of Waterloo, as well as a Doctor of Philosophy degree in Biochemistry from McMaster University. The start and end years for each degree are not provided, so further information regarding the duration of their education is unknown.